18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)

JIA, WEIPING; MA, JIANHUA; MIAO, HENG; WANG, CHANGJIANG; WANG, XIAOYUE; LI, QUANMIN; LU, WEIPING; YANG, JIALIN; ZHANG, LIHUI; YANG, JINKUI; WANG, GUIXIA; ZHANG, XIUZHENG; ZHANG, MIN; SUN, LI; YU, XUEFENG; DU, JIANLING; SHI, BINGYIN; XIAO, CHANGQING; ZHU, DALONG; LIU, HONG; ZHONG, LIYONG; XU, CHUN; XU, QI; LIANG, GANXIONG; ZHANG, YING; LI, GUANGWEI; GU, MINGYU; LIU, JUN; NING, ZHIQIANG; JI, LINONG

doi:10.2337/db19-18-OR

Article navigation

OR: Clinical Therapeutics/New Technology—Other Therapeutic Agents| June 01 2019

18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)

WEIPING JIA;

WEIPING JIA

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

JIANHUA MA;

JIANHUA MA

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

HENG MIAO;

HENG MIAO

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

CHANGJIANG WANG;

CHANGJIANG WANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

XIAOYUE WANG;

XIAOYUE WANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

QUANMIN LI;

QUANMIN LI

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

WEIPING LU;

WEIPING LU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

JIALIN YANG;

JIALIN YANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

LIHUI ZHANG;

LIHUI ZHANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

JINKUI YANG;

JINKUI YANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

GUIXIA WANG;

GUIXIA WANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

XIUZHENG ZHANG;

XIUZHENG ZHANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

MIN ZHANG;

MIN ZHANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

LI SUN;

LI SUN

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

XUEFENG YU;

XUEFENG YU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

JIANLING DU;

JIANLING DU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

BINGYIN SHI;

BINGYIN SHI

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

CHANGQING XIAO;

CHANGQING XIAO

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

DALONG ZHU;

DALONG ZHU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

HONG LIU;

HONG LIU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

LIYONG ZHONG;

LIYONG ZHONG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

CHUN XU;

CHUN XU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

QI XU;

QI XU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

GANXIONG LIANG;

GANXIONG LIANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

YING ZHANG;

YING ZHANG

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

GUANGWEI LI;

GUANGWEI LI

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

MINGYU GU;

MINGYU GU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

JUN LIU;

JUN LIU

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

ZHIQIANG NING;

ZHIQIANG NING

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

LINONG JI

Shanghai, China, Nanjing, China, Hefei, China, Yueyang, China, Beijing, China, Huai'an, China, Shijiazhuang, China, Changchun, China, Siping, China, Wuhan, China, Dalian, China, Xi'an, China, Nanning, China, Shantou, China, Zhongshan, China, Guangzhou, China, Shenzhen, China

Search for other works by this author on:

This Site

PubMed

Google Scholar

Diabetes 2019;68(Supplement_1):18-OR

https://doi.org/10.2337/db19-18-OR

Chiglitazar, a novel PPARα/γ/δ pan-agonist, showed favorable effects on glycemic control and lipid modulation with well tolerated safety profile in phase 2 trials. This trial aimed to compare the efficacy and safety of chiglitazar with DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled with diet and exercise (ClinicalTrials.gov NCT02173457). Patients were randomly assigned to receive chiglitazar 32 mg or 48 mg, or sitagliptin 100 mg once daily. The primary endpoint was change in HbA1c from baseline at week 24, with a non-inferiority of each chiglitazar dose versus sitagliptin. Analysis was done in all randomized patients who received at least one dose of study drug (n=739). Chiglitazar showed comparable HbA1c lowering effect compared with sitagliptin at 24 weeks (LS mean difference -0.04% [95% CI -0.22 to 0.15] and -0.08% [95% CI -0.27 to 0.10] for 32 mg and 48 mg, respectively), along with different trends in secondary endpoints. Overall adverse events were comparable across study groups. The incidences of weight gain and edema were generally low but relatively higher in chiglitazar 48 mg.

In conclusion, chiglitazar showed non-inferior effect compared with sitagliptin on HbA1c reduction with well tolerated safety profile.

View large Download slide

Disclosure

W. Jia: None. J. Ma: None. H. Miao: None. C. Wang: None. X. Wang: None. Q. Li: None. W. Lu: None. J. Yang: None. L. Zhang: None. J. Yang: None. G. Wang: None. X. Zhang: None. M. Zhang: None. L. Sun: None. X. Yu: None. J. Du: None. B. Shi: None. C. Xiao: None. D. Zhu: None. H. Liu: None. L. Zhong: None. C. Xu: None. Q. Xu: None. G. Liang: None. Y. Zhang: None. G. Li: None. M. Gu: None. J. Liu: None. Z. Ning: None. L. Ji: Advisory Panel; Self; AstraZeneca. Consultant; Self; AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck KGaA, Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk A/S, Roche Pharma, Sanofi, Takeda Pharmaceutical Company Limited. Research Support; Self; AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis AG, Roche Pharma, Sanofi.

Funding

Ministry of Science and Technology of the People´s Republic of China (2013ZX09401301)

2019

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only